Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences Network (WABNet), Senegal
March 10, 2016
Government's role in developing solutions for diseases that disproportionately affect developing countries
Introduction: -Inequalities in health and food security keep widening between developed and developing countries, esp. SSA e.g. infant mortality rate, TB prevalence, food production rate less than population growth rate.
Safe development & application of biotech to address these face a number of challenges.
Dear Colleagues,This month marks my one-year anniversary as BIO’s CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
Re: BIO Comments on Office of Management and Budget (OMB) Statistical Policy Directive No. 8 North American Industry Classification System (NAICS)-Request forComments on Possible Revisions for 2027 (USBC–2024–0032)Dear Ms. Orvis,The Biotechnology…
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
Government's role in developing solutions for diseases that disproportionately affect developing countries
Introduction:
-Inequalities in health and food security keep widening between developed and developing countries, esp. SSA e.g. infant mortality rate, TB prevalence, food production rate less than population growth rate.
Safe development & application of biotech to address these face a number of challenges.